Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Another Deal For Google’s Calico
by Michael McCoy
April 6, 2015
| A version of this story appeared in
Volume 93, Issue 14
Calico Labs, the mysterious Google-backed biotech firm studying age-related diseases, has signed another deal, this one with the University of California, San Francisco, for technology discovered by Peter Walter, a professor of biochemistry and biophysics at the school. For an undisclosed payment, Calico will license technology for small-molecule modulators of the integrated stress response, a set of cellular processes that may contribute to memory decline. Calico also has deals with QB3, a University of California institute; AbbVie; and the Broad Institute of MIT & Harvard.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter